Literature DB >> 323317

Detection of functional complement components in gingival crevicular fluid from humans with periodontal diseases.

F J Courts, R J Boackle, H H Fudenberg, M S Silverman.   

Abstract

Crevicular fluid was collected from patients with periodontitis by a capillary tube procedure. Complement component activities were determined by functional assay systems, with human complement, and partially purified human first complement component (C1) as controls. The complement-fixing properties of the dental plaque of each patient were also examined C1 activity in the crevicular fluid of all patients was approximately 1/8 of whole serum C1 and diminished rapidly with time after collection. There was no significant relationship between C1 concentration and crevicular fluid flow rate. Hemolytic activity of whole complement was also invariable detected when sufficient amounts (8 micronl) of crevicular fluid could be obtained. Dental plaque was found to fix C1. A role for crevicular complement in inflammatory periodontal disease is suggested.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 323317     DOI: 10.1177/00220345770560032001

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  25 in total

Review 1.  Complementary Tolls in the periodontium: how periodontal bacteria modify complement and Toll-like receptor responses to prevail in the host.

Authors:  Jennifer L Krauss; Jan Potempa; John D Lambris; George Hajishengallis
Journal:  Periodontol 2000       Date:  2010-02       Impact factor: 7.589

Review 2.  Revisiting the Page & Schroeder model: the good, the bad and the unknowns in the periodontal host response 40 years later.

Authors:  George Hajishengallis; Jonathan M Korostoff
Journal:  Periodontol 2000       Date:  2017-10       Impact factor: 7.589

3.  Gingival Exudatome Dynamics Implicate Inhibition of the Alternative Complement Pathway in the Protective Action of the C3 Inhibitor Cp40 in Nonhuman Primate Periodontitis.

Authors:  Nagihan Bostanci; Kai Bao; Xiaofei Li; Tomoki Maekawa; Jonas Grossmann; Christian Panse; Ruel A Briones; Ranillo R G Resuello; Joel V Tuplano; Cristina A G Garcia; Edimara S Reis; John D Lambris; George Hajishengallis
Journal:  J Proteome Res       Date:  2018-08-29       Impact factor: 4.466

Review 4.  Complement and dysbiosis in periodontal disease.

Authors:  George Hajishengallis; John D Lambris
Journal:  Immunobiology       Date:  2012-11       Impact factor: 3.144

Review 5.  Complement and periodontitis.

Authors:  George Hajishengallis
Journal:  Biochem Pharmacol       Date:  2010-06-23       Impact factor: 5.858

6.  Inhibition of pre-existing natural periodontitis in non-human primates by a locally administered peptide inhibitor of complement C3.

Authors:  Tomoki Maekawa; Ruel A Briones; Ranillo R G Resuello; Joel V Tuplano; Evlambia Hajishengallis; Tetsuhiro Kajikawa; Sophia Koutsogiannaki; Cristina A G Garcia; Daniel Ricklin; John D Lambris; George Hajishengallis
Journal:  J Clin Periodontol       Date:  2016-03-03       Impact factor: 8.728

7.  Genetic and intervention studies implicating complement C3 as a major target for the treatment of periodontitis.

Authors:  Tomoki Maekawa; Toshiharu Abe; Evlambia Hajishengallis; Kavita B Hosur; Robert A DeAngelis; Daniel Ricklin; John D Lambris; George Hajishengallis
Journal:  J Immunol       Date:  2014-05-07       Impact factor: 5.422

Review 8.  Basic biology and role of interleukin-17 in immunity and inflammation.

Authors:  Camille Zenobia; George Hajishengallis
Journal:  Periodontol 2000       Date:  2015-10       Impact factor: 7.589

Review 9.  Role of complement in host-microbe homeostasis of the periodontium.

Authors:  George Hajishengallis; Toshiharu Abe; Tomoki Maekawa; Evlambia Hajishengallis; John D Lambris
Journal:  Semin Immunol       Date:  2013-05-16       Impact factor: 11.130

10.  Streptococcus mutans dextransucrase: stimulation by phospholipids from human sera and oral fluids.

Authors:  C F Schachtele; S K Harlander; J W Bracke; L C Ostrum; J A Maltais; R J Billings
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.